Bernstock, J. D., Bag, A. K., Fiveash, J., Kachurak, K., Elsayed, G., Chagoya, G., . . . Friedman, G. K. (2020). Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther.
Citação norma ChicagoBernstock, Joshua D., et al. "Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors." Hum Gene Ther 2020.
Citação norma MLABernstock, Joshua D., et al. "Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors." Hum Gene Ther 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.